BIOLIFE SOLUTIONS INC

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services designed to maintain the quality and viability of biologic materials used across the cell and gene therapy sector. The company operates as a single bioproduction segment with three primary product offerings: cell processing and other products, biopreservation media, and automated thawing devices. Key proprietary lines include HypoThermosol and CryoStor preservation media, human platelet lysate media, specialized rigid containers, automated filling machinery, and water-free thawing instruments. Its customer base includes researchers, clinical trial sponsors, and commercial manufacturers of cell and gene therapies.

The company operates two clean room production suites in Bothell, Washington, and one clean room facility in Indianapolis, Indiana. In addition, its automated thawing devices are manufactured by a contract manufacturing organization located in the United States. BioLife Solutions markets its products globally through direct sales representatives and regional third-party distributors across the United States, Europe, the Middle East, Africa, and other international markets. The company maintains its principal executive offices in Bothell, Washington.

Summary of the business section of Biolife Solutions's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we had 155 full-time team members and no part-time team members.”